powerpoint 簡報eng.tty.com.tw/rwd1181/store/f3/tty company profile... · 2018. 11. 14. · world...

43

Upload: others

Post on 04-Oct-2020

1 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Culture and tty

March, 2017 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_20170317.pdf · TTY Biopharm is a global leader in Super-Generic Drugs and novel bio-drug development with strong

台灣東洋藥品法人說明會 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · 2018-04-18 · drugs– Lipo-Dox & UFUR launched, 2000 Traded on the Taiwan GTSM (4105),

PowerPoint 簡報 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · 2018. 11. 13. · Market cap US$856mn. ... Systemic Fungal Infection Leuprolide Acetate Injection

March, 2019 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile...2009 EMEA Official 2010 Jordan Official 2011 Germany Official Brazil Official 2012 Japan Official 2013 US FDA

December, 2017 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · 2018. 4. 16. · Market cap US$906mn. As of 6/30/2017 Currently has three major subsidiaries (based on

September, 2016 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_20160907.pdf · TTY’s ROE 19.2% in 2011-2015, ROE 24.1% in 2015 (above industry average 7.35%). TTY targets

December, 2018ch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_201812...Potential Global Market Size 23 Global existing MS treatment market value 2016 2017 2018 2019 2020 2021 2022

December, 2017 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · Global estimation MS treatment market rising from $17.2 billion to $20 billion (YoY) from 2014 to 2024

Slayton Tty Museum

TTY Biopharm Company Limitedeng.tty.com.tw/rwd1181/store/F3/TTY Consolidated... · Stock Code:4105 TTY BIOPHARM COMPANY LIMITED AND SUBSIDIARIES Consolidated Financial Statements

PowerPoint 簡報 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_201805... · 2018-11-13 · $1,000M $1,200M $1,400M $1,600M Second-Line, Target Penetration, $3,000 Price

April, 2017 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · TSH Biopharm (listed), Market cap US$85mn, 56.48%; CY Biotech, 27.54% Shareholder value creation- TTY’s

TTY BIOPHARM COMPANY LIMITEDeng.tty.com.tw/rwd1181/store/F3/Shareholder Meeting... · Audit Committee’s Review Report on the 2016 Financial Statements (See Attachment 2) 3. Report

September, 2017 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile_20170907EN… · Global estimation MS treatment market rising from $17.2 billion to $20 billion (YoY) from

PowerPoint 簡報 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_202005.pdf · 依據gri標準編製企業社會責任(csr)報告書且連續4年榮獲公司治理評鑑

December, 2016ch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_20161215.pdf · TTY’s ROE 19.2% in 2011-2015, ROE 24.1% in 2015 (above industry average 7.35%). TTY targets for

PowerPoint 簡報 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · 2018-04-18 · Somatostatin binds to somatostatin receptors (SST R), exert a variety of physiological

PowerPoint 簡報 - eng.tty.com.tweng.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · TTY’s ROE 19.2% in 2011-2015, ROE 24.1% in 2015 (above industry average 7.35%). TTY targets

台灣東洋藥品工業股份有限公司eng.tty.com.tw/rwd1181/store/F3/Shareholder Meeting... · 2016 Business Report and Financial Statements. Description: 1. The Company’s

December, 2018 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile_201812EN.pdf · Global estimation MS treatment market rising from $20.59 billion to $27.38 billion from 2016

PowerPoint 簡報 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_201905...2 Uveitis (葡萄膜炎) (眼睛發炎) >0.531B Humira (2016) 3 Neuropathic Pain (神經性疼痛)

Behavioral Health: Dents: TTY 711 TTY 711 044-308-7151 TTY 711 TTY 711 For Provldorg Waw.itnltndhealthcareantino Dental providers: ww,vdbp.cvrn IJHC For Pharmacists 1£77-8W65t0 Claims

Terminal With Your LifeGNU Screen tmux... TTY driver The terminal multiplexers handle the TTY drivers. TTY driver And these applications connect TTY driver: Terminal.app(macOS)

March, 2019 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile_201903... · 2019-04-01 · Potential Market Size $348.3M $776.1M $928.8M $97.5M $218.3M $259.9M $95.3M $213.6M

TTY SIEMENS INTARFACE

The TTY Demystified

TTY Rakennustalo

TTY Biopharm Company Limitedeng.tty.com.tw/rwd1181/store/F3/Lonsurf1.pdf · 2.2 15 1,500/ á ž/*ñèR . 4 á , , 5 5 , 15 (15 trifluridine/7.065 tipiracil hydrochloride) 20 æž(20

March, 2018 - TTYch.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · 2018-04-16 · (Lipo-Dox) 轉移性乳癌、愛滋病引發之卡波西氏肉瘤、 Pegylipo 多發性骨髓瘤、卵巢癌

March, 2018 - TTYeng.tty.com.tw/rwd1181/store/F3/TTY Company Profile... · 2018-11-13 · Diseases (CV/GI/Immune) ... (Lipo-Dox) Metastatic breast cancer BC, AIDS-related Kaposi’s

r2018 - TTYeng.tty.com.tw › rwd1181 › store › F3 › TTY Annual Report 2018.pdf · Same Investment Businesses, as well as the Combined Calculated Shareholding Percentage

TTY Biopharm Company Limitedeng.tty.com.tw/rwd1181/store/F3/TTY Non... · Stock Code:4105 TTY BIOPHARM COMPANY LIMITED Financial Statements with Independent Auditors' Report For the

Tty teta palveluliiketoiminta_marras2012_mmm